Hello,
Welcome to
- See the pitch deck Swift Medical used to raise $35 million for its approach to wound care;
- We spoke to fully vaccinated people who got COVID-19 about what it was like to have a breakthrough infection;
- At a Stat event, Eli Lilly's CEO shared the company's plans to treat obesity with an experimental diabetes medication.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...
Quick housekeeping note:
See the presentation Swift Medical, a 3D imaging startup for wound care, used to raise $35 million
- Swift Medical has an app that uses AI and 3D imaging to remotely manage wound care.
- The app was primarily designed for nurses and clinicians caring for chronic-wound patients.
See the presentation that the cofounder and CEO Carlo Perez used to raise $35 million>>
Fully vaccinated people who got COVID-19 describe their mild symptoms, and their relief that they'd gotten a shot
- The COVID-19
vaccines are extremely effective, but a rare few vaccinated people have gotten sick. - "Breakthrough" infections are typically mild and might be less contagious than regular cases.
- To completely prevent infections, more of the population needs to get vaccinated.
Eli Lilly's CEO is betting its experimental diabetes drug could transform how we treat obesity
- Eli Lilly's CEO thinks tirzepatide, an experimental diabetes treatment, could also treat obesity.
- In a clinical trial, people with diabetes who received tirzepatide lost on average 25 pounds.
- There are few effective weight-loss drugs available.
More stories we're reading:
- How 4 of the US's most vaccinated counties got shots to more than 70% of their residents (Insider)
- Deaths from drug overdoses jumped by nearly 30% in 2020 to more than 93,000 (Washington Post)
- South Korea bans fast-paced music in gyms and limits treadmill speeds to a walk as COVID-19 cases soar (Insider)
- Stat grilled acting FDA Commissioner Janet Woodcock about the agency's controversial Alzheimer's approval (Stat News)
- Lydia